Article Details

Seattle biotech firm Umoja Biopharma raises $53M as it tackles unique approach to immunotherapy

Retrieved on: 2020-11-19 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Seattle biotech firm Umoja Biopharma raises $53M as it tackles unique approach to immunotherapy. View article details on hiswai:

Excerpt

MPM Capital and <b>Qiming Venture Partners</b> USA led the Series A round, which included participation from DCVC Bio. “Umoja is comprised of a highly ...

Article found on: www.geekwire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo